Search

Learn how MSK's world-class Head and Neck cancer specialists help people facing throat cancer, using the latest therapies and innovations.

… Thursday, September 4, 2025 Throat cancer is a form of head and neck cancer. It starts in the throat (known as the pharynx), which includes the tonsils, back of the tongue, voice box (larynx), and the vocal cords. Some of these areas can be seen when the mouth is wide open and others only by a camera

Find in-depth information about bile duct cancer (cholangiocarcinoma) and how Memorial Sloan Kettering can help.

… This information is about bile duct cancer. Read more about gallbladder cancer. If you or someone you care about has been diagnosed with bile duct cancer, you may have a lot of questions. Where should you go for care? What are your treatment options? How can you keep your quality of life? This guide

Manager, Clinical Data at Flatiron Health, New York, NY

… Job Title Manager, Clinical Data at Flatiron Health, New York, NY Since taking AP biology in high school and seeing all of the amazing things going on inside of a tiny cell, I have liked that, in science, answers tend to raise more questions. The ability to uncover something that no one else ever has

… Job Title Weill Cornell Graduate Student Degree MS

… The Prasad Jallepalli Lab There is a postdoctoral fellow position open in the Jallepalli laboratory.  Applicants with strong interests in cell cycle regulation and chromosome biology, and relevant expertise in genetics, cell biology, biochemistry, and/or chemical biology, should contact the Principal

… Xiong Y, Taleb M, Misawa K, Hou Z, Banerjee S, Amador-Molina A, Jones DR, Chintala NK, Adusumilli PS . c-Kit signaling potentiates CAR T-cell efficacy in solid tumors by CD28- and IL-2–independent costimulation. Nat Cancer . 2023;4(7):1001-1015. [PMID: 37336986] Quach HT, Skovgard MS, Villena-Vargas

… Job Title Fellow Email [email protected]

The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.”

… Wednesday, July 22, 2020 The July 22 MSK Science Spotlight features Luis Diaz, MD , Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.” An accomplished physician, pioneering researcher, and leader in the field

You may have heard that the U.S. Food and Drug Administration (FDA) approved elacestrant for postmenopausal women or adult men with estrogen receptor (ER)-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer on January 27, 2023. In addition, the FDA also approved the Guardant360 CDx assay, a companion liquid biopsy diagnostic device for identifying patients for treatment.

… Wednesday, March 8, 2023 You may have heard that the U.S. Food and Drug Administration (FDA) approved elacestrant for postmenopausal women or adult men with estrogen receptor (ER)-positive, HER2-negative, ESR1 -mutated advanced or metastatic breast cancer on January 27, 2023. In addition, the FDA also

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.

… Monday, October 8, 2012 Summary Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells. For the first time, a team of Memorial Sloan Kettering investigators has synthesized erythropoietin (also known as EPO), the hormone